GTR Test Accession:
Help
GTR000029927.9
CAP
Last updated in GTR: 2023-11-29
View version history
GTR000029927.9, last updated: 2023-11-29
GTR000029927.8, last updated: 2022-11-29
GTR000029927.7, last updated: 2021-11-29
GTR000029927.6, last updated: 2018-12-24
GTR000029927.5, last updated: 2017-12-14
GTR000029927.4, last updated: 2016-12-29
GTR000029927.3, last updated: 2016-01-12
GTR000029927.2, last updated: 2016-01-06
GTR000029927.1, last updated: 2014-01-23
Last annual review date for the lab: 2023-11-29
LinkOut
At a Glance
Test purpose:
Help
Mutation Confirmation;
Diagnosis
Conditions (1):
Help
Alpha-1-antitrypsin deficiency
Genes (1):
Help
SERPINA1 (14q32.13)
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: Pyrosequencing
Target population: Help
Alpha1-antitrypsin deficiency (α1ATD, AATD) is suspected in individuals with evidence …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Peripheral (whole) blood
- Isolated DNA
- View specimen requirements
Who can order: Help
- Nurse Practitioner
- Physician Assistant
- Health Care Provider
- Licensed Physician
Test Order Code:
Help
AATM
Lab contact:
Help
Sophia Hauxwell, Manager
shauxwell@nebraskamed.com
402-559-5104
Allison Cushman-Vokoun, PhD, MD, Medical Director
acushman@unmc.edu
402-559-3512
shauxwell@nebraskamed.com
402-559-5104
Allison Cushman-Vokoun, PhD, MD, Medical Director
acushman@unmc.edu
402-559-3512
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Call Regional Pathology Services at 800-334-0459 to set up a new account.
Order URL
Order URL
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
No
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Test strategy
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Targeted variant analysis
Pyrosequencing
PyroMark Q24 System
Clinical Information
Test purpose:
Help
Mutation Confirmation;
Diagnosis
Clinical utility:
Help
Target population:
Help
Alpha1-antitrypsin deficiency (α1ATD, AATD) is suspected in individuals with evidence of pulmonary disease (i.e., emphysema, asthma, persistent airflow obstruction, and/or chronic bronchitis) and/or evidence of liver disease at any age, including obstructive jaundice in infancy. AATD is also observed rarely in individuals with Wegener granulomatosis and necrotizing panniculitis.
View citations (1)
- Stoller JK, Hupertz V, Aboussouan LS. Alpha-1 Antitrypsin Deficiency. 2006 Oct 27 [updated 2023 Jun 01]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. PMID: 20301692.
Recommended fields not provided:
Clinical validity,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
Amplified products are subjected to pyrosequencing analysis to identify mutations in the Z and S deficiency alleles.
Test Platform:
None/not applicable
Test Comments:
Help
Mutation panel: Z (p.E342K) and S (p.E264V) mutations.
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
This assay detects the two most common deficiency alleles, known as Z (p.E342K) and S (p.E264V). Assay does not distinguish the normal variants of alpha 1 antitrypsin known as M, M1, and M2.
View citations (1)
- Rapid and simple diagnosis of the two common alpha 1-proteinase inhibitor deficiency alleles Pi*Z and Pi*S by DNA analysis. Braun A, et al. Eur J Clin Chem Clin Biochem. 1996;34(9):761-4. doi:10.1515/cclm.1996.34.9.761. PMID: 8891530.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Clinical resources:
Molecular resources:
Practice guidelines:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.